Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Oligodendroglioma 1Mesothelioma, Malignant 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Ependymoma 1Astrocytoma 1

Interventions

Magnetic Resonance Spectroscopy 6Temozolomide 3Radiotherapy 3Magnetic Resonance Imaging 3Yoga 2Surgical Procedures, Operative 2Gadolinium DTPA 2Biopsy 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2gallium Ga 68 dotatate 1gadobutrol 1gadobenic acid 1fluorodopa F 18 1alovudine 1Vincristine 1Surveys and Questionnaires 1Restraint, Physical 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1O(6)-benzylguanine 1Neuropsychological Tests 1Mind-Body Therapies 1Methotrexate 1Meditation 1Heart Rate 1Gelclair 1Fluorescein 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Astrocytoma × Etanidazole × Clear all
NCT00430079 2013-01-16

Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma

National Cancer Institute (NCI)

Phase NA Terminated
48 enrolled
CNSSarcoma

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡